130 related articles for article (PubMed ID: 8603353)
1. c-MYC amplification in a case of progression from MDS to AML (M2).
de Souza Fernandez T; Silva ML; De Souza J; De Paula MT; Abdelhay E
Cancer Genet Cytogenet; 1996 Feb; 86(2):183-4. PubMed ID: 8603353
[No Abstract] [Full Text] [Related]
2. IS THE AMPLIFICATION OF c-MYC, MLL AND RUNX1 GENES IN AML AND MDS PATIENTS WITH TRISOMY 8, 11 AND 21 A FACTOR FOR A CLONAL EVOLUTION IN THEIR KARYOTYPE?
Angelova S; Spassov B; Nikolova V; Christov I; Tzvetkov N; Simeonova M
Tsitol Genet; 2015; 49(3):25-32. PubMed ID: 26214902
[TBL] [Abstract][Full Text] [Related]
3. Double minute chromosomes in a patient with myelodysplastic syndrome transforming into acute myeloid leukemia.
Michalová K; Cermák J; Brezinová J; Zemanová Z
Cancer Genet Cytogenet; 1999 Feb; 109(1):76-8. PubMed ID: 9973965
[TBL] [Abstract][Full Text] [Related]
4. Clonal selection of 11q CN-LOH and CBL gene mutation in a serially studied patient during MDS progression to AML.
Barresi V; Palumbo GA; Musso N; Consoli C; Capizzi C; Meli CR; Romano A; Di Raimondo F; Condorelli DF
Leuk Res; 2010 Nov; 34(11):1539-42. PubMed ID: 20674974
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation.
Ohanian M; Bueso-Ramos C; Ok CY; Lin P; Patel K; Alattar ML; Khoury JD; Rozovski U; Estrov Z; Huh YO; Cortes J; Abruzzo LV
Cancer Genet; 2015 Nov; 208(11):571-4. PubMed ID: 26382622
[TBL] [Abstract][Full Text] [Related]
6. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype.
Huh YO; Tang G; Talwalkar SS; Khoury JD; Ohanian M; Bueso-Ramos CE; Abruzzo LV
Cancer Genet; 2016; 209(7-8):313-20. PubMed ID: 27318442
[TBL] [Abstract][Full Text] [Related]
7. MDS and AML with trisomy 8 as the sole chromosome aberration show different sex ratios and prognostic profiles: a study of 115 published cases.
Pedersen B
Am J Hematol; 1997 Dec; 56(4):224-9. PubMed ID: 9395183
[TBL] [Abstract][Full Text] [Related]
8. Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomes.
Badar T; Patel KP; Thompson PA; DiNardo C; Takahashi K; Cabrero M; Borthakur G; Cortes J; Konopleva M; Kadia T; Bohannan Z; Pierce S; Jabbour EJ; Ravandi F; Daver N; Luthra R; Kantarjian H; Garcia-Manero G
Leuk Res; 2015 Dec; 39(12):1367-74. PubMed ID: 26547258
[TBL] [Abstract][Full Text] [Related]
9. Co-existence of pseudo-Chediak-Higashi anomaly and double minutes containing C-MYC oncogene in three patients with AML M2.
Golovleva I; Hultdin J; Roos G; Wahlin A; Holmgren G
Leukemia; 2002 Jan; 16(1):152-4. PubMed ID: 11840276
[No Abstract] [Full Text] [Related]
10. Trisomy 4 associated with double minute chromosomes and MYC amplification in acute myeloblastic leukemia.
Receveur A; Ong J; Merlin L; Azgui Z; Merle-Béral H; Berger R; Nguyen-Khac F
Ann Genet; 2004; 47(4):423-7. PubMed ID: 15581842
[TBL] [Abstract][Full Text] [Related]
11. Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia.
Meggendorfer M; de Albuquerque A; Nadarajah N; Alpermann T; Kern W; Steuer K; Perglerová K; Haferlach C; Schnittger S; Haferlach T
Haematologica; 2015 Dec; 100(12):e487-90. PubMed ID: 26294738
[No Abstract] [Full Text] [Related]
12. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
[TBL] [Abstract][Full Text] [Related]
13. Amplification of c-MYC oncogene and point mutation of N-RAS oncogene point mutation in acute myelocytic leukemias with double minute chromosomes.
Tanaka K; Takechi M; Nishimura S; Oguma N; Kamada N
Leukemia; 1993 Mar; 7(3):469-71. PubMed ID: 8445953
[TBL] [Abstract][Full Text] [Related]
14. Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia.
Nakagawa T; Saitoh S; Imoto S; Itoh M; Tsutsumi M; Hikiji K; Nakamura H; Matozaki S; Ogawa R; Nakao Y
Oncology; 1992; 49(2):114-22. PubMed ID: 1574246
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
[TBL] [Abstract][Full Text] [Related]
17. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
Niimi H; Harada H; Harada Y; Ding Y; Imagawa J; Inaba T; Kyo T; Kimura A
Leukemia; 2006 Apr; 20(4):635-44. PubMed ID: 16467864
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells.
Larsson N; Billström R; Lilljebjörn H; Lassen C; Richter J; Ekblom M; Fioretos T
Cancer Genet Cytogenet; 2010 Jun; 199(2):89-95. PubMed ID: 20471511
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP
Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347
[TBL] [Abstract][Full Text] [Related]
20. [Research progress on mechanism of MDS transformation into AML].
Wang LL; Gao C; Chen BA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):254-9. PubMed ID: 21362264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
